Immune map for pancreatic cancer evolution
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study builds an immune map of how pancreatic cancer changes over time. It may help doctors better understand the disease and find new treatment strategies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy person with no liver, gallbladder, or pancreas diseases.
- You have been diagnosed with pancreatic ductal adenocarcinoma (PDAC).
- You have a benign (non-cancerous) pancreatic tumor.
- You have been diagnosed with IPMN (intraductal papillary mucinous neoplasm) by imaging or pathology.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses advanced imaging to detect pancreatic cancer early and track how well treatment is working. It may help if you have pancreatic cancer that can be surgically removed, either right away or after chemotherapy.
This trial tests a new treatment using your own immune cells (called CAR-T cells) that are modified to target a protein called B7-H3 found on pancreatic cancer cells. The goal is to see if this therapy can help shrink or control the cancer.
This trial tests a new immune cell therapy (EGFRBi armed PBMC) for people with advanced pancreatic cancer that can't be removed by surgery. It aims to see if this treatment can help control the cancer after you've already tried at least one type of chemotherapy and your disease is stable or better.
This study is looking for a new way to catch pancreatic cancer early by checking your immune system's signals. It compares people with pancreatic cancer, people with non-cancerous pancreatic growths, and healthy volunteers to find a simple blood test that could help diagnose the disease sooner.
This trial studies a new blood test that looks for cancer-specific immune cells after surgery for pancreatic cancer. It aims to see if the test can detect any remaining cancer cells earlier than standard methods, which could help guide further treatment decisions.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
Hear when a new Pancreas Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.